drugset
drugset / Trial / NCT02849873

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

NCT02849873 ↗

Phase 1 Completed 48 enrolled Bausch Health Americas, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison with Tazorac Cream.

Timeline

Start
2016-06
Primary completion
2016-12
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tazarotene Small molecule — Topical

Indications

acne